We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current IFRX market cap is 147.8M. The company's latest EPS is EUR -0.7246 and P/E is -3.46.
| Quarter End | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 4.88M | 3k | 36k | 6k | 124k |
| Operating Income | -9.85M | -13.31M | -12.49M | -15.4M | -15.36M |
| Net Income | -8.2M | -15.93M | -9.66M | -13.85M | -17.45M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 400k | 222k | 54k | 20.16M | 63k |
| Operating Income | -56.77M | -33.94M | -47.63M | -32.24M | -44.91M |
| Net Income | -53.26M | -33.98M | -45.63M | -29.48M | -42.67M |
| Quarter End | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 132.96M | 120.21M | 107.1M | 93.04M | 79.69M |
| Total Liabilities | 8.32M | 17.63M | 12.34M | 10.88M | 14.41M |
| Total Equity | 124.65M | 102.58M | 94.76M | 82.16M | 65.28M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 121.58M | 88.22M | 125.14M | 102.4M | 120.21M |
| Total Liabilities | 14.43M | 10.35M | 19.86M | 14.05M | 17.63M |
| Total Equity | 107.15M | 77.86M | 105.28M | 88.35M | 102.58M |
| Quarter End | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -21.69M | -37.81M | -14.87M | -27M | -36.66M |
| Investing | -27.89M | -17.7M | 26.95M | 32.94M | 50.41M |
| Financing | 53.18M | 52.99M | -86k | -193k | -290k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -43.2M | -36.53M | -39.94M | -33.74M | -37.81M |
| Investing | 20.34M | 21.36M | -25.95M | 19.36M | -17.7M |
| Financing | -294k | 9.17M | 61.58M | 1.94M | 52.99M |
| Market Cap | 147.8M |
| Price to Earnings Ratio | -3.46 |
| Price to Sales Ratio | 2.28k |
| Price to Cash Ratio | 11.58 |
| Price to Book Ratio | 1.44 |
| Dividend Yield | - |
| Shares Outstanding | 58.88M |
| Average Volume (1 week) | 585.61k |
| Average Volume (1 Month) | 525.29k |
| 52 Week Change | 83.21% |
| 52 Week High | 2.815 |
| 52 Week Low | 1.165 |
| Spread (Intraday) | 0.08 (3.19%) |
| Company Name | InflaRx NV |
| Address |
winzerlaer jena 07745 |
| Website | https://www.inflarx.de |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
